ProQR Therapeutics NV (PRQR)
1.66
0.00 (0.00%)
USD |
NASDAQ |
Jun 26, 14:54
ProQR Therapeutics Cash and Short Term Investments (Quarterly): 110.92M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 110.92M |
| December 31, 2023 | 131.46M |
| September 30, 2023 | 127.60M |
| June 30, 2023 | 139.71M |
| March 31, 2023 | 151.56M |
| December 31, 2022 | 101.64M |
| September 30, 2022 | 98.71M |
| June 30, 2022 | 163.38M |
| March 31, 2022 | 187.08M |
| December 31, 2021 | 212.32M |
| September 30, 2021 | 181.11M |
| June 30, 2021 | 165.94M |
| March 31, 2021 | 79.57M |
| December 31, 2020 | 93.28M |
| September 30, 2020 | 104.31M |
| June 30, 2020 | 98.00M |
| March 31, 2020 | 108.16M |
| December 31, 2019 | 125.40M |
| September 30, 2019 | 81.83M |
| June 30, 2019 | 93.76M |
| March 31, 2019 | 105.65M |
| Date | Value |
|---|---|
| December 31, 2018 | 120.77M |
| September 30, 2018 | 132.14M |
| June 30, 2018 | 38.12M |
| March 31, 2018 | 46.85M |
| December 31, 2017 | 57.70M |
| September 30, 2017 | 46.82M |
| June 30, 2017 | 48.41M |
| March 31, 2017 | 55.69M |
| December 31, 2016 | 62.58M |
| September 30, 2016 | 72.83M |
| June 30, 2016 | 84.88M |
| March 31, 2016 | 96.86M |
| December 31, 2015 | 103.72M |
| September 30, 2015 | 112.53M |
| June 30, 2015 | 119.32M |
| March 31, 2015 | 123.25M |
| December 31, 2014 | 137.09M |
| September 30, 2014 | 146.25M |
| June 30, 2014 | 52.11M |
| December 31, 2013 | 5.702M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
79.57M
Minimum
Mar 2021
212.32M
Maximum
Dec 2021
127.79M
Average
118.16M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| uniQure NV | 555.68M |
| Merus NV | 337.50M |
| argenx SE | -- |
| Pharming Group | 201.97M |
| Pharvaris NV | 397.77M |